2026-525230-27-00CompletedPhase 1
Bioequivalence clinical trial of two formulations of rosuvastatin.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 5 Mar 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- First submitted
- 5 Feb 2026
- Start date
- 23 Feb 2026
- Lead sponsor
- Laboratorios Alter S.A.
- EU CT number
- 2026-525230-27-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 36
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario de la Princesa | Madrid | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.